Charlotte Casebourne is the founder of Theolytics. Theolytics has raised $25M in total funding. Latest round: Series A. Based in Oxford, England.
Charlotte Casebourne Stock co-founded Theolytics, a clinical-stage biotechnology company in Oxford, England, which focuses on using viruses to combat disease. She previously served as CEO until July 2024, at which point she transitioned to an advisory role to pursue other entrepreneurial endeavors.
Full founder directory · Investor directory · Company funding database · Fundraising library